HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Andrew S. Wechsler Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abd-Elfattah, A. S. Articles by Wechsler, A. S. Search for Related Content PubMed PubMed Citation Articles by Abd-Elfattah, A. S. Articles by Wechsler, A. S.

J Thorac Cardiovasc Surg 1995;110:328-339
© 1995 Mosby, Inc.

CARDIOPULMONARY BYPASS, MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES

INTERMITTENT AORTIC CROSSCLAMPING PREVENTS CUMULATIVE ADENOSINE TRIPHOSPHATE DEPLETION, VENTRICULAR FIBRILLATION, AND DYSFUNCTION (STUNNING): IS IT PRECONDITIONING?

Richmond, Va.

Supported in part by an AHA-VA grant-in-aid 90-G-44 and NIH grant HL-5-1090 (ASA).

Received for publication April 28, 1994. Accepted for publication Dec. 20, 1994. Address for reprints: Anwar S Abd-Elfattah, PhD, Department of Surgery, Medical College of Virginia, P.O. Box 98052, Richmond, VA 23298-0532.

Abstract

This study was designed to determine whether intermittent warm aortic crossclamping induces cumulative myocardial stunning or if the myocardium becomes preconditioned after the first episode of ischemia in canine models in vivo. The role of adenosine triphosphate catabolism and subsequent release of purines on reperfusion-mediated postischemic ventricular dysfunction and arrhythmias was assessed with the use of selective inhibitors of nucleoside transport, p-nitrobenzylthioinosine (NBMPR), and a specific adenosine deaminase inhibitor, erythro-9-[2-hydroxy-3-nonyl] adenine (EHNA). Thirty-two anesthetized dogs were instrumented to monitor left ventricular contractility, off bypass, by sonomicrometry. During cardiopulmonary bypass dogs were treated before ischemia with either saline solution (control group, n = 8) or EHNA (100µmol/L) and NBMPR (25µmol/L) (EHNA/NBMPR group, n = 8). Hearts were subjected to either 60 minutes of global ischemia and 120 minutes of reperfusion (n = 16) or 6 episodes of 10 minutes of global ischemia and 10 minutes of reperfusion, followed by 60 minutes of reperfusion (n = 16). Sixty minutes of sustained ischemia resulted in 80% loss of adenosine triphosphate and induced reperfusion-mediated ventricular fibrillation and severe left ventricular dysfunction in the control group. EHNA/NBMPR treatment augmented myocardial adenosine trapping during ischemia, attenuated ventricular fibrillation, and enhanced left ventricular functional recovery, despite similar depletion of adenosine triphosphate (80% loss). In the intermittent ischemia experiment, the first episode of 10 minutes of ischemia and reperfusion caused significant adenosine triphosphate depletion, ventricular fibrillation, and left ventricular stunning in both control and drug-treated groups. The prevalence of ventricular fibrillation was greater in the control group than in the drug-treated group after the first episode of ischemia (p < 0.05). Adenosine was the major nucleoside accumulated in the myocardium at the end of 10 minutes of ischemia in the EHNA/NBMPR-treated group (p < 0.05 versus control). Subsequent episodes of ischemia prevented ventricular fibrillation and did not cause cumulative left ventricular stunning in either group. Left ventricular function fully recovered in the EHNA/NBMPR-treated group after intermittent ischemia, but remained stunned in the control group. Unlike sustained ischemia, intermittent ischemia and reperfusion preserved myocardial adenosine triphosphate, limited purine release, and prevented ventricular fibrillation and cumulative stunning. These results suggest that intermittent ischemia and reperfusion augmented the endogenous protective mechanism or mechanisms of "preconditioning." Nucleoside trapping improved functional recovery after sustained or repetitive ischemia. It is concluded that adenosine triphosphate preservation or blockade of nucleoside transport may play an important role in the activation of endogenous myocardial protective mechanisms that "precondition" against subsequent ischemic stress. (J THORACCARDIOVASCSURG1995;110:328-39)

This article has been cited by other articles:

				Z. Zhu, P. A. Hofmann, and J. K. Buolamwini Cardioprotective effects of novel tetrahydroisoquinoline analogs of nitrobenzylmercaptopurine riboside in an isolated perfused rat heart model of acute myocardial infarction Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2921 - H2926. [Abstract] [Full Text] [PDF]

				M. Fujii and D. J. Chambers Myocardial protection with intermittent cross-clamp fibrillation: does preconditioning play a role? Eur. J. Cardiothorac. Surg., December 1, 2005; 28(6): 821 - 831. [Abstract] [Full Text] [PDF]

				M. Fujii, M. Avkiran, and D. J Chambers Experimental studies on myocardial protection with intermittent cross-clamp fibrillation: additive effect of the sodium-hydrogen exchanger inhibitor, cariporide Ann. Thorac. Surg., April 1, 2004; 77(4): 1398 - 1407. [Abstract] [Full Text] [PDF]

				J. Alex, V. P. Rao, A. R.J. Cale, S. C. Griffin, M. E. Cowen, and L. Guvendik Surgical nurse assistants in cardiac surgery: a UK trainee's perspective Eur. J. Cardiothorac. Surg., January 1, 2004; 25(1): 111 - 115. [Abstract] [Full Text] [PDF]

				J. Alex, J. Ansari, R. Guerrero, J. Yogarathnam, A. R.J. Cale, S. C. Griffin, M. E. Cowen, and L. Guvendik Comparison of the immediate post-operative outcome of two different myocardial protection strategies: antegrade-retrograde cold St Thomas blood cardioplegia versus intermittent cross-clamp fibrillation Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 584 - 588. [Abstract] [Full Text] [PDF]

				L. Raco, E. Mills, and R. J.W. Millner Isolated myocardial revascularization with intermittent aortic cross-clamping: experience with 800 cases Ann. Thorac. Surg., May 1, 2002; 73(5): 1436 - 1439. [Abstract] [Full Text] [PDF]

				U. Sunderdiek, P. Feindt, and E. Gams Aortocoronary bypass grafting: a comparison of HTK cardioplegia vs. intermittent aortic cross-clamping Eur. J. Cardiothorac. Surg., October 1, 2000; 18(4): 393 - 399. [Abstract] [Full Text] [PDF]

				R. Bessho and D. J. Chambers Experimental study of intermittent crossclamping with fibrillation and myocardial protection: Reduced injury from shorter cumulative ischemia or intrinsic protective effect? J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 528 - 537. [Abstract] [Full Text] [PDF]

				L. P. Perrault and P. Menasche Preconditioning: can nature’s shield be raised against surgical ischemic-reperfusion injury? Ann. Thorac. Surg., November 1, 1999; 68(5): 1988 - 1994. [Abstract] [Full Text] [PDF]

				G. Valen, S. Takeshima, and J. Vaage Preconditioning Improves Cardiac Function After Global Ischemia, But Not After Cold Cardioplegia Ann. Thorac. Surg., November 1, 1996; 62(5): 1397 - 1403. [Abstract] [Full Text]

				L. P. Perrault, P. Menasche, A. Bel, T. de Chaumaray, J. Peynet, A. Mondry, P. Olivero, R. Emanoil-Ravier, and J.-M. Moalic ISCHEMIC PRECONDITIONING IN CARDIAC SURGERY: A WORD OF CAUTION J. Thorac. Cardiovasc. Surg., November 1, 1996; 112(5): 1378 - 1386. [Abstract] [Full Text]

				A. K. Ganjoo and W. D. Johnson Cardioprotective effects of ischemic preconditioning J. Thorac. Cardiovasc. Surg., July 1, 1996; 112(1): 208 - 208. [Full Text]